In CKD anemia management, what is the initial step to evaluate and guide therapy?

• A. Iron studies to assess iron status; consider ESA if iron adequate
• B. Immediate ESA therapy without iron studies
• C. Transfusion of packed RBCs
• D. Hydration to stimulate EPO production

Answer: (A)

The key idea is that restoring and maintaining adequate iron stores is the foundation of treating CKD-related anemia. Erythropoiesis-stimulating agents can boost red cell production, but they work only if iron is available for hemoglobin synthesis. Therefore, the first step is to check iron status with iron studies (ferritin and transferrin saturation). If iron stores are adequate, an ESA can be started or adjusted to address the anemia. If iron is not adequate, iron replacement should come first (and ESAs are used once iron is sufficient) to ensure a proper and effective response.

Starting ESAs without confirming iron status risks a poor response and can worsen iron-restricted erythropoiesis. Transfusing packed RBCs is reserved for more urgent situations or severe symptomatic anemia, not the initial management. Hydration won’t meaningfully stimulate EPO production, so it isn’t a strategy for correcting CKD anemia.